Vivek Kumbhari
Papers
2
Total Citations
41
H-Index
2
About
Dr. Vivek Kumbhari is a leading interventional gastroenterologist whose research centers on advanced endoscopic therapies for esophageal and gastric disorders, particularly gastroesophageal reflux disease (GERD) and achalasia. His major contributions include pioneering comparative effectiveness studies that demonstrate the clinical and economic advantages of peroral endoscopic myotomy (POEM) over traditional surgical approaches. His landmark 2017 study, cited 37 times, showed that POEM achieves equivalent clinical response to robotic Heller myotomy while incurring significantly lower charges, establishing a strong evidence base for endoscopic myotomy as a first-line therapy. Dr. Kumbhari has also advanced the field of endoscopic management of complications from anti-reflux devices, as illustrated by his 2021 work on the novel use of a mechanical biliary lithotriptor to remove an eroded LINX® device—a minimally invasive solution to a challenging surgical problem. His research consistently bridges the gap between endoscopic innovation and practical patient care, demonstrating that less invasive procedures can match or exceed surgical outcomes while reducing healthcare costs. Through these contributions, Dr. Kumbhari has positioned himself as a key figure shaping the future of therapeutic endoscopy.
Research Focus
Key Achievements
Top Papers
- 1
- 2